JW Lifescience Corporation (KRX:234080)
South Korea · Delayed Price · Currency is KRW 11,040
+90 (0.82%)
Last updated: Jun 24, 2026, 2:24 PM KST
JW Lifescience Market Cap
JW Lifescience has a market cap or net worth of 170.64 billion as of June 24, 2026. Its market cap has decreased by -7.94% in one year.
Market Cap
170.64B
Enterprise Value
200.69B
Revenue
252.72B
Ranking
n/a
PE Ratio
5.85
Stock Price
11,040.00
Market Cap Chart
Since October 27, 2016, JW Lifescience's market cap has decreased from 340.05B to 170.64B, a decrease of -49.82%. That is a compound annual growth rate of -6.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 170.64B | -14.24% |
| Dec 30, 2025 | 198.98B | 18.11% |
| Dec 30, 2024 | 168.47B | -15.46% |
| Dec 28, 2023 | 199.29B | 5.93% |
| Dec 29, 2022 | 188.14B | -12.27% |
| Dec 30, 2021 | 214.46B | -34.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Boditech Med | 207.52B |
| Suheung | 202.01B |
| Chong Kun Dang Holdings | 192.09B |
| Whan In Pharm | 187.43B |
| Daewon Pharmaceutical | 183.04B |
| REYON Pharmaceutical | 181.39B |
| BNC KOREA | 180.56B |
| HLB Pharmaceutical | 171.04B |